David Lee Scher, M.D. pushes for adoption of mobile technologies for clinical trials

In Clinical6 by Brandy ReedLeave a Comment

In David Lee Scher, M.D.’s latest blog post, he discusses how mobile technology is the solution for clinical trials. He says, “Improving patient recruiting, retention, and data collection should be the priorities of any mobile technology in this space.” Scher offers Parallel 6’s Clinical Reach technology as a solution that is already active in the life science arena and integrating into clinical trials.

Scher says, ” One might intuitively think that a clinical trial mobile app might simply consist of a technology limited to data and symptom entry. But the dynamics and workflows of all phases of a clinical trial make that a recipe for poor recruiting and lack of patient engagement and thus retention. Parallel 6 is a company which utilizes patented technology in its end to end mobile clinical trial technology for improving both the recruiting and retention of study subjects. In addition, pharmaceutical companies are realizing the power of crowdsourced studies.”

Some of the other key takeaways that we found from Scher’s blog post were:

1. Social media is a valuable tool for running clinical trials

At Parallel 6, our team of digital strategists is most interested in social media for it’s value for clinical trial recruitment. Scher takes notice of this when he says, “It can facilitate recruitment of patients with rare diseases who reside in widely dispersed geographical regions.” He continues with other benefits of social media for clinical trials such as participation. One study found that “patients who are actively engaged in the use of social media for healthcare information are 60% more likely to have participated in a clinical trial compared to the general population.” This could have a positive effect on gender bias and improve evidence-based clinical trials.

2. Traditional methods for clinical trial research are too costly to keep up

Mobile will be the solution that keeps clinical trials running. It’s a cost-friendly solution that will encourage sponsors and healthcare enterprises to continue funding for clinical trials. A recent report by the Department of Health and Human Services projected that for each phase of of a trial, mobile technologies will save millions of dollars. The highest areas of savings can be seen in phases 3 and 4 whenever savings can range from $3 to $7 million.

3. Mobile can improve trail safety and efficiency

Mobile solutions such as Clinical Reach offer real-time data during a clinical trial. This means that physicians are able to respond to patient symptoms sooner and improve processes. This will further improve patient satisfaction and retain patients in the trial, also saving money in the process. Clinical Reach is also CFR Part 11 Compliant, so in addition to patient safety, the physician running the trail can feel secure knowing that their electronic data is protected.

What other ways do you think that mobile technologies will improve the life, cost and engagement for clinical trials?

Leave a Comment